Document is current
Any future updates will be listed below
-
Authors
Yang, Zhao
Wang, Xiaodan
Niu, Mengyue
Wei, Qiao
Zhong, Huizhu
Li, Xiaoyan
Yuan, Weihong
Xu, Wenli
Zhu, Shuo
Yu, Shengyuan
Liu, Jun
Yan, Jianzhou
Kang, Wenyan
Huang, Peijian
-
Funding
Funding for this research was provided by:
Pfizer (88668477)
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 20 September 2024
First Online: 27 September 2024
Declarations
:
: All participants provided written informed consent before enrolment. The participants were informed that their personal deidentified study-related data would be used in accordance with local privacy and data protection laws. The study protocol was approved by the Institutional Ethics Committees of Ruijin Hospital-Shanghai Jiao Tong University School of Medicine in China.
: Not applicable.
: The authors declare no competing interests.
